The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer

    Research output: Contribution to journalArticlepeer-review

    43 Downloads (Pure)


    The mitogen-activated protein kinase (MAPK) kinase 4 (MKK4) is a nonredundant component of stress-activated MAPK signaling modules. Its function in tumorigenesis remains highly controversial with some studies indicating that MKK4 is a tumor suppressor, whereas others have reported a pro-oncogenic role. To clarify the role of MKK4 in cancer, we have created a novel mouse model to test the effect of the specific loss of MKK4 in the epidermis on the formation of papillomas caused by activated ras mutation. We have discovered that skin-specific MKK4-deficient mice are resistant to carcinogen-induced tumorigenesis. One mechanism by which MKK4 promotes cell proliferation and the formation of tumors is by increasing epidermal growth factor receptor expression through the c-Jun NH2-terminal protein kinase/c-Jun signaling pathway. Together, our results provide the first genetic demonstration that MKK4 is essential to mediate the oncogenic effect of Ras in vivo, thereby validating MKK4 as a potential drug target for cancer therapy. ©2010 AACR.
    Original languageEnglish
    Pages (from-to)5797-5806
    Number of pages9
    JournalCancer Research
    Issue number14
    Publication statusPublished - 15 Jul 2010


    Dive into the research topics of 'The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer'. Together they form a unique fingerprint.

    Cite this